Evolving Strategies to Cover High Investment Medications
Please note: This session is NOT accredited for continuing pharmacy education (CPE) credit.
Novel therapies, such as gene and cell therapy, are growing in availability and meeting medical needs for previously uncurable conditions. These important and life-saving options are associated with high initial costs raising predictability, affordability, and accessibility concerns for managed care organizations. This session will discuss various perspectives on alternative payment models, financial tools, and policy initiatives that mitigate risk and improve access to these durable cures.
Jane Barlow, MD, MPH, MBA
Chief Clinical Officer
Mehb Khoja, FSA, MAAA
Gail Ryan, PharmD
Director of Pharmaceutical Transformation
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.